Scholtz & Company’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.5M | Sell |
43,877
-5,320
| -11% | -$601K | 2.31% | 16 |
|
|
2025
Q4 | $6.16M | Buy |
49,197
+1,150
| +2% | +$147K | 2.68% | 12 |
|
|
2025
Q3 | $6.44M | Buy |
48,047
+1,414
| +3% | +$186K | 2.83% | 11 |
|
|
2025
Q2 | $6.34M | Sell |
46,633
-735
| -2% | -$96.9K | 2.78% | 11 |
|
|
2025
Q1 | $6.28M | Sell |
47,368
-93
| -0.2% | -$11.8K | 3.11% | 11 |
|
|
2024
Q4 | $5.37M | Buy |
47,461
+5,902
| +14% | +$682K | 2.56% | 14 |
|
|
2024
Q3 | $4.74M | Buy |
41,559
+903
| +2% | +$99K | 2.24% | 16 |
|
|
2024
Q2 | $4.22M | Buy |
40,656
+33,624
| +478% | +$3.57M | 1.8% | 22 |
|
|
2024
Q1 | $799K | Sell |
7,032
-7,885
| -53% | -$904K | 0.35% | 34 |
|
|
2023
Q4 | $1.64M | Sell |
14,917
-19,716
| -57% | -$1.97M | 0.81% | 34 |
|
|
2023
Q3 | $3.35M | Sell |
34,633
-3,216
| -8% | -$338K | 2.21% | 18 |
|
|
2023
Q2 | $4.13M | Sell |
37,849
-1,326
| -3% | -$141K | 2.58% | 14 |
|
|
2023
Q1 | $3.97M | Sell |
39,175
-560
| -1% | -$59.1K | 2.83% | 15 |
|
|
2022
Q4 | $4.36M | Sell |
39,735
-995
| -2% | -$103K | 3.09% | 12 |
|
|
2022
Q3 | $4.24M | Sell |
40,730
-13,336
| -25% | -$1.42M | 3.03% | 11 |
|
|
2022
Q2 | $5.87M | Sell |
54,066
-3,115
| -5% | -$354K | 3.61% | 8 |
|
|
2022
Q1 | $6.77M | Buy |
57,181
+456
| +0.8% | +$56.5K | 2.67% | 11 |
|
|
2021
Q4 | $7.98M | Sell |
56,725
-18,190
| -24% | -$2.33M | 2.58% | 12 |
|
|
2021
Q3 | $8.85M | Sell |
74,915
-10,070
| -12% | -$1.24M | 3.13% | 7 |
|
|
2021
Q2 | $9.85M | Buy |
84,985
+2,035
| +2% | +$237K | 3.37% | 6 |
|
|
2021
Q1 | $9.94M | Buy |
82,950
+2,342
| +3% | +$277K | 3.78% | 6 |
|
|
2020
Q4 | $8.83M | Sell |
80,608
-4,236
| -5% | -$460K | 3.45% | 6 |
|
|
2020
Q3 | $9.23M | Buy |
84,844
+300
| +0.4% | +$30.4K | 4.03% | 6 |
|
|
2020
Q2 | $7.73M | Buy |
84,544
+1,254
| +2% | +$113K | 3.86% | 6 |
|
|
2020
Q1 | $6.57M | Buy |
83,290
+8,995
| +12% | +$751K | 5.03% | 5 |
|
|
2019
Q4 | $6.45M | Buy |
74,295
+2,475
| +3% | +$207K | 3.75% | 7 |
|
|
2019
Q3 | $6.01M | Buy |
71,820
+46
| +0.1% | +$3.91K | 4.01% | 7 |
|
|
2019
Q2 | $6.04M | Buy |
71,774
+5,085
| +8% | +$400K | 3.91% | 7 |
|
|
2019
Q1 | $5.33M | Buy |
66,689
+792
| +1% | +$58.9K | 3.55% | 10 |
|
|
2018
Q4 | $4.77M | Buy |
65,897
+10,087
| +18% | +$709K | 4.14% | 10 |
|
|
2018
Q3 | $4.09M | Buy |
+55,810
| New | +$3.66M | 2.58% | 16 |
|
Other funds holding ABT
VCM
VPM
Scholtz & Company's ABT Position: Q1 2026 in Review
Scholtz & Company reduced its Abbott (ABT) stake by 11% in Q1 2026, selling an estimated $601K and leaving 43,877 shares worth $4.5M. The position accounts for 2.31% of the portfolio, ranked #16.
Scholtz & Company first reported a position in ABT in Q3 2018 and has held it in 31 quarters since. The position peaked at $9.94M in Q1 2021. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- Scholtz & Company held 43,877 shares of Abbott worth $4.5M as of Q1 2026.
- Scholtz & Company sold 5,320 Abbott shares in Q1 2026, an estimated $601K.
- Abbott made up 2.31% of Scholtz & Company's portfolio in Q1 2026, its #16 holding.
- Scholtz & Company first reported a position in Abbott in Q3 2018 and has held it in 31 quarters since.
- Scholtz & Company's Abbott position peaked at $9.94M in Q1 2021.
- 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on Scholtz & Company's 13F filing for Q1 2026, filed 15 May 2026.